X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
esomeprazole (221) 221
humans (146) 146
omeprazole (138) 138
index medicus (128) 128
pharmacology & pharmacy (105) 105
proton pump inhibitors (103) 103
male (90) 90
female (71) 71
lansoprazole (60) 60
adult (56) 56
middle aged (53) 53
gastroenterology & hepatology (51) 51
pharmacokinetics (48) 48
pantoprazole (43) 43
chemistry, analytical (41) 41
gastroesophageal-reflux disease (41) 41
esomeprazole - administration & dosage (40) 40
rabeprazole (40) 40
animals (39) 39
omeprazole - chemistry (37) 37
aged (36) 36
proton pump inhibitor (36) 36
gastroesophageal reflux - drug therapy (33) 33
medicine & public health (33) 33
biochemistry, general (32) 32
esomeprazole - chemistry (32) 32
stereoisomerism (32) 32
hydrogen-ion concentration (31) 31
chemistry, medicinal (30) 30
chemistry, multidisciplinary (30) 30
drugs (29) 29
treatment outcome (29) 29
gastroenterology (28) 28
proton pump inhibitors - chemistry (28) 28
esomeprazole - therapeutic use (27) 27
anti-ulcer agents - administration & dosage (26) 26
enantiomers (26) 26
oncology (26) 26
therapy (25) 25
chemistry, organic (24) 24
gastroesophageal reflux (23) 23
hepatology (23) 23
transplant surgery (23) 23
anti-ulcer agents - therapeutic use (22) 22
biochemical research methods (22) 22
dose-response relationship, drug (22) 22
proton pump inhibitors - therapeutic use (22) 22
adolescent (21) 21
analysis (21) 21
double-blind method (21) 21
esomeprazole - pharmacokinetics (21) 21
gastroesophageal reflux disease (21) 21
proton pump inhibitors - administration & dosage (21) 21
validation (21) 21
young adult (21) 21
erosive esophagitis (20) 20
esomeprazole - pharmacology (20) 20
proton pump inhibitors - pharmacology (20) 20
administration, oral (18) 18
biochemistry & molecular biology (18) 18
cross-over studies (18) 18
double-blind (18) 18
drug interactions (18) 18
drug therapy, combination (18) 18
efficacy (18) 18
proton-pump inhibitor (18) 18
esomeprazole - adverse effects (17) 17
methods (17) 17
proton pump inhibitors - adverse effects (17) 17
time factors (17) 17
drug therapy (16) 16
omeprazole - administration & dosage (16) 16
omeprazole - pharmacology (16) 16
proton pump inhibitors - pharmacokinetics (16) 16
aged, 80 and over (15) 15
anti-ulcer agents - chemistry (15) 15
chemistry, pharmaceutical (15) 15
chemistry, physical (15) 15
drug stability (15) 15
gastric acid - secretion (15) 15
hplc (15) 15
naproxen (15) 15
pharmacology/toxicology (15) 15
rats (15) 15
reproducibility of results (15) 15
safety (15) 15
sulfides (15) 15
symptoms (15) 15
2-pyridinylmethylsulfinylbenzimidazoles (14) 14
abridged index medicus (14) 14
esomeprazole magnesium (14) 14
omeprazole - pharmacokinetics (14) 14
oxidation (14) 14
pharmacology (14) 14
pharmacy (14) 14
prospective studies (14) 14
anti-ulcer agents - pharmacology (13) 13
asymmetric oxidation (13) 13
dosage and administration (13) 13
management (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Managed Care, ISSN 1088-0224, 2014, Volume 20, Issue 3, pp. e90 - e97
Objectives: A "chiral switch" occurs in the pharmaceutical market when a drug made up of 2 enantiomer forms is replaced with a purified single-enantiomer... 
MEDICATION | NAMES | MULTICENTER | EROSIVE ESOPHAGITIS | OMEPRAZOLE | RANDOMIZED CONTROLLED-TRIAL | 8-WEEK COMPARATIVE TRIAL | MEDICINE, GENERAL & INTERNAL | COST | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | HEALTH POLICY & SERVICES | HEALTH | Proton Pump Inhibitors - economics | Formoterol Fumarate | Hypnotics and Sedatives - chemistry | Medicaid - economics | Stereoisomerism | United States | Humans | Dexmethylphenidate Hydrochloride - chemistry | Drugs, Generic - economics | Piperazines - economics | Esomeprazole - chemistry | Drug Approval | Piperazines - chemistry | Esomeprazole - economics | Eszopiclone | Azabicyclo Compounds - chemistry | Benzhydryl Compounds - chemistry | Antidotes - economics | Bronchodilator Agents - chemistry | Levoleucovorin - chemistry | Histamine H1 Antagonists, Non-Sedating - economics | Dexmethylphenidate Hydrochloride - economics | Dexlansoprazole - chemistry | Retrospective Studies | Central Nervous System Stimulants - economics | United States Food and Drug Administration | Wakefulness-Promoting Agents - chemistry | Levoleucovorin - economics | Antidotes - chemistry | Bronchodilator Agents - economics | Azabicyclo Compounds - economics | Benzhydryl Compounds - economics | Cetirizine - chemistry | Cetirizine - economics | Ethanolamines - economics | Ethanolamines - chemistry | Patents as Topic | Hypnotics and Sedatives - economics | Wakefulness-Promoting Agents - economics | Drug Prescriptions - statistics & numerical data | Proton Pump Inhibitors - chemistry | Central Nervous System Stimulants - chemistry | Dexlansoprazole - economics | Histamine H1 Antagonists, Non-Sedating - chemistry | Clinical trials | Prescription drugs | Trends | Comparative analysis
Journal Article
Journal Article
Drug Development and Industrial Pharmacy, ISSN 0363-9045, 09/2016, Volume 42, Issue 9, pp. 1495 - 1503
Journal Article
Journal Article
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 09/2015, Volume 58, Issue 11-12, pp. 433 - 441
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2007, Volume 321, Issue 3, pp. 866 - 874
Journal Article